MIT scientists believe the future is bright for antibiotics discovery

Who do we blame for the return of polio?

Genentech goes beyond pharmaceutical manufacturing in its work with members of the SMA community. Michael Dunn explains

For any organization, one ill-timed tweet can create enormous backlash.

CEO and Founder of EnteroBiotix James McIllroy shares the wonders of manipulating our microbial passengers.

A growing number of deaths linked to pediatric medicines prompts the WHO to investigate “unacceptable” levels of APIs.

Regeneron Pharmaceuticals’ Israel Lowy explains how a positive CHMP opinion can become good news for cancer patients

How critical anti-cancer drugs can be sustainably developed from genetically engineered baker’s yeast.

Historic challenges in ADC Development have not thwarted some players

AMR remains a pressing issue, but hydroquinine has yielded some interesting effects on clinically important bacteria